Effect of vitamin D3 on maturation and antigen-presenting function of dendritic cells treated with Mycobacterium tuberculosis  by Liu, Chun-Yu et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(1): 54–5754Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2015.12.011*Corresponding author: Xu Jian-Zhong, M.D, Department of Orthopaedics, First
Afﬁliated Hospital of Third Military Medical University, Sichuan 400038, China.
Tel: +86 023 68754164
E-mail: xjzslw@163.com
Peer review under responsibility of Hainan Medical College.
1995-7645/Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. This is an open access arti
creativecommons.org/licenses/by-nc-nd/4.0/).Effect of vitamin D3 on maturation and antigen-presenting function of dendritic cells treated with
Mycobacterium tuberculosisChun-Yu Liu1, Ze-Hua Zhang2, Hui-Feng Yang3, Hui Xu1, Fei-Fan Cheng2, Jian-Zhong Xu2*1No 202 Hospital of People's Liberation Army, Liaoning 110003, China
2Department of Orthopedics, Southwest Hospital, Third Military Medical, Chongqing 400038, China
3Department of Orthopedics, General Hospital of Shenyang Military, Liaoning 110016, ChinaARTICLE INFO
Article history:
Received 15 Oct 2015
Received in revised form 20 Nov
2015
Accepted 3 Dec 2015
Available online 19 Dec 2015
Keywords:
25(OH)D3
Dendritic cells
Mycobacterium tuberculosisABSTRACT
Objective: To investigate the phenotypic characteristics and functional capability dif-
ferences of mouse bone marrow-derived dendritic cells after stimulation with Myco-
bacterium tuberculosis in the presence or absence of vitamin D3.
Methods: Mouse bone marrow-derived cells were cultured with GM-CSF (20 ng/mL).
Then, one was added with 100 nmol/L of 25(OH)D3, while the other did not. On day 6,
5 mg/mL of BCG was added to stimulate the cells for 24 h. On day 7, suspension cells
were harvested for phenotypic and functional analyses.
Results: The percentages of CD86 dendritic cells (DCs) in the control group and 25(OH)
D3 group were 66.97% ± 8.29% and 52.18% ± 8.52%, respectively; the mean ﬂuores-
cence intensities of MHC-II in the control group and 25(OH)D3 group were 1
102.16 ± 371.02 and 681.62 ± 292.71. The expression levels of MHC- II and CD86 on
the surface of the DCs in 25(OH)D3 group were signiﬁcantly lower than those of the
control group. The ability of the DCs to stimulate proliferation of T-lymphocytes was also
signiﬁcantly lower than that of the control group.
Conclusions: These ﬁndings suggest that 25(OH)D3 modulates the immune response by
affecting the maturation and function of DCs in Mycobacterium tuberculosis period.1. Introduction
Tuberculosis is a globally common disease which severely
threatens human health. According to statistics, more than one
million people died from tuberculosis in some years [1]. 25(OH)D3
is an important active compoundof vitaminD3. It is a good index of
detecting the level of vitamin D3. In 1940s, 25(OH)D3was used to
treat tuberculosis because it had a calciﬁcation effect on sites of
tuberculosis disease. But with the developments and applications
of anti-tuberculosis drugs, the use of 25(OH)D3 in tuberculosis
therapy decreased generally [2,3]. However, problems gradually
emerged in the process of using anti-tuberculosis drugs. For
instance, many patients represented drug resistant tuberculosis [4,5].
Traditional anti-tuberculosis drugs do not show satisfactory efﬁ-
cacy. Therefore, we rethink that whether we should reuse 25(OH)
D3 to treat tuberculosis and whether we should continuously
explore its action mechanism. At present, although there are lots ofreports on treating tuberculosis, there is no agreement. Some reports
claimed that 25(OH)D3 could not only treat tuberculosis and
improve clinical efﬁcacy, but also improve the imaging manifes-
tations of tuberculosis patients [6]. However, some other reports
argued that 25(OH)D3 had bare effects on improving clinical
efﬁcacy of tuberculosis patients [7]. Thus, the effects of 25(OH)
D3 on treating tuberculosis needs further explorations.
There were researches showing that 25(OH)D3 had participated
in the occurrence of the body tuberculosis immunity [8,9]. Not long
ago, literature researches revealed that 25(OH)D3 inﬂuenced the
innate immune mechanism of tuberculosis [10,11]. But there are no
studies about the concrete mechanism of 25(OH)D3 in
tuberculosis acquired immune. Dendritic cells (DCs) play an
important role in the process of initiating tuberculosis acquired
immune [12–14]. Researches in vitro and in vivo showed that the
phagocytosis function of DCs decreased and its expressions of
superﬁcial co-stimulatory molecules and antigen-presenting mol-
ecules increased after phagocytizing mycobacterium Mycobacte-
rium tuberculosis, whichmeant that those cells tended to bemature.
When DCs are mature, the expressions of their superﬁcial mole-
cules increase, such as MHC-II, MHC-I, CD80, CD86 and so on
[15,16]. In addition, the latest research showed that when antigencle under the CC BY-NC-ND license (http://
Table 1
Expressions of CD11C, MHC-II, CD80 and CD86 between the two
groups (%).
Groups CD11C MHC-II CD80 CD86
Control
group
83.99 ± 3.20 87.62 ± 3.23 85.28 ± 7.39 66.97 ± 8.29
Group 25
(OH)D3
81.13 ± 5.18 84.99 ± 3.17 85.11 ± 8.02 52.18 ± 8.52
t 1.485 1.838 0.049 3.934
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initiates and starts to work [17]. So, there have been many reports
about the effects of 25(OH)D3 in the maturity of CDs [18], but
there are fewer researches about the inﬂuential mechanism of
25(OH)D3 in DCs whenMycobacterium tuberculosis infects.
Hence, the main purpose of the study is to investigate the
functional capability differences of mouse bone marrow-derived
dendritic cells after stimulation with Mycobacterium tubercu-
losis in the presence or absence of vitamin D3.
2. Materials and methods
2.1. In vitro cultivation of DCs
The experimental methods were acquired from adjusted Inaba.
The main processes were as follows: 4–8 week-old male mice
without speciﬁc pathogen were provided by Laboratory Animal
Center of Third Military Medical University. After breaking
necks to death, bilateral femurs and tibias were taken out and
soaked in 70% of alcohol for 2 min. After that, femurs and tibias
were taken out from that and soaked in uncompleted PRMI-1640-
cultured medium. The process should keep aseptic strictly. Then
both ends of the femurs and tibias were cut and the bone marrow
cells were washed out by sterile syringe which had absorbed the
uncompleted PRMI-1640-cultured medium. The bone marrow
cells were centrifuged with speed of 1 200 rpm for 8 min after
blowing and beating evenly. Then, they were cultivated in the
completed PRMI-1640-cultured medium after discarding the su-
pernatants and suspended again. According to a density of
2.5 × 105/mL, they were inoculated 24-pore plates (0.5 mL a
pore) after adding 20 ng/mL of rmGM-CSF cytokines into them.
Then, 100 nmol/L of 25(OH)D3 were added into group 25(OH)
D3. The control group did not. On the next day, 0.4 mL cultured
medium were suctioned out from the 24-pore plates and supple-
mented completed PRMI-1640-cultured medium with 20 ng/mL
of rmGM-CSF. On the fourth day, 0.25 mL cultured medium
were suctioned out; cells were collected by centrifugation and
suspended again in 24-pore plates by 0.25 mL fresh completed
PRMI-1640-cultured medium with 20 ng/mL of rmGM-CSF. On
the sixth day, cells were collected and suspended by centrifuga-
tion according the methods of day four and were made to be
mature by stimulation of 5 mg/mL of BCG after resuspension. On
day seven, the mature DCs were collected and invert microscope
was used to observe the morphologies of DCs at all states.
2.2. Analysis and identiﬁcation of the ﬂow cytometric
phenotype of DCs
DCs which had cultivated to the last day were centrifuged with
the speed of 800 rpm/min for 10 min; the supernatants were dis-
carded again; then, PBS was used to wash them to make sure the
density of cells was 5 × 105/mL. Next, 0.5 mL of FITC-labelled
CD11C, CD86, CD80 and MHC-II were respectively added into
them and used to make isotype control. After mixing evenly, they
were placed in 4 C dark environment for 30 min; then, they were
taken out, washed and tested by ﬂow cytometry ﬁnally.
2.3. Mixed lymphocytes reaction
After putting those mice to death, their spleens were
taken out immediately. Fewer RPMI 1640 cultured mediumwere added into it and monocytes were separated and then
mixed lymphocytes were separated. It then became allogeneic
mixed T-lymphocytes after being cultivated in the 37 C incu-
bator with 5% CO2 for 4 h. According to the four
cells proportions 1:200, 1:100, 1:50 and 1:20, mature DCs were
used to make mixed-lymphocytes reaction with CD4+ T in 96-
pores plate. There were three complex pores of each group to
cultivate for 96 h and 37kBq 3H2TdR was added to cultivate for
16 h according to the standard of 1 m Ci a pore. The value of
cpm was detected by liquid scintillation counter.
2.4. Lacks of mice model building and the detections of
CD4+ T cells and CD8+ T cells of 25(OH)D3
BALB/C mice were divided randomly into 25(OH)D3 and the
control groups. Mice in 25(OH)D3 group were fed with normal
fodders with vitamin D and given lights in the day and no lights at
nights. Mice in the control group, however, were fed with fodders
without vitamin D, covered with blackout fabric and given yellow
light (without ultraviolet ray) in the day and no lights at nights.Mice
of both groups were fed for 12 weeks. Ten of them were randomly
taken out and 0.05 mg of BCG was injected into tail vein of then.
Then, they were taken back to the previous environment to be
continuously fed for 6 weeks. After that, they were broken necks to
death to make lymphocytes suspension; 360 mL of a lymphocytes
suspensions were absorbed and placed in two EP tubes respectively
with 18 mL of each tube. Rabbit antimouse CD3e-PE and CD4-
FITC were added into one tube. In the other tube, rabbit anti-
mouse CD3e-PE and CD8-FITC were added into it, which was the
control group. Both were analyzed by ﬂow cytometer.
2.5. Statistical analysis
SPSS17.0 was used to make statistical analysis.
Mean ± standard deviation was used to represented expression
quantity of DCs' surface molecules, mean ﬂuorescent intensity
and the level of T-cells’ multiplication. t-Test was used to make
intergroup comparison. Percentage form was used to show the
positive rate of DCs’ surface molecules.
3. Results
3.1. Morphology of DCs
After two days of cultivation, fewer short and small dendritic
protrusions could be observed on someDCs’ surface; after six days
of cultivation, it could be observed that the number of dendritic
protrusions increased and there were agglomerate cell colonies in
some parts. There were many longer and mature DCs releasingP 0.155 0.083 0.961 0.001
Table 2
Average ﬂuorescence intensities of CD11C, MHC-II, CD80 and CD86 between the two groups.
Groups CD11C MHC-II CD80 CD86
Control group 445.19 ± 129.82 1102.16 ± 371.02 350.11 ± 101.18 149.18 ± 29.13
Group 25(OH)D3 444.21 ± 109.28 681.62 ± 292.71 341.01 ± 113.27 139.15 ± 25.91
t 0.018 2.814 0.189 0.814
P 0.986 0.011 0.852 0.427
Figure 1. Multiplication levels of CD4+ T cells of the two groups were
compared. *P < 0.05.
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increased and protrusions became more and longer.
3.2. Phenotypic analysis of DCs
DCs which were separated from mice’s bone marrows were
cultured by rmGM-CSF; 5 mg/ml of BCG were added to stim-
ulate their maturity on the sixth day. Flow cytometry was
applied to test the expressions of their surface molecules. The
averages of the positive rates of CD11C, MHC-II, CD86 and
CD80 were 89.73%, 94.17%, 69.12% and 92.16%; the positive
rates and purity of DCs were pretty low. It indicated that the
differentiated and mature abilities of separated-cultured DCs
were comparatively ideal and could be used for the subsequent
experiences and researches.
3.3. Inhibited DCs from mature by 25(OH)D3
The expression of CD86 of the control group was signiﬁ-
cantly higher than that of the 25(OH)D3. (P < 0.05) (Table 1).
Among them, the average of ﬂuorescence intensity of MHC-II in
the control group was signiﬁcantly higher than that in 25(OH)D3
(P < 0.05) (Table 2).
3.4. Inhibited antigen presenting function of DCs by
25(OH)D3
Compared with group 25(OH)D3, the DCs of the control
group signiﬁcantly improved the multiplication level of CD4+ T
cells (Figure 1).Table 3
Effect of 25(OH)D3 in the distribution of CD4+ T and CD8+ T.
Groups CD4+ T(%) CD8+ T(%) CD4+ T/CD8+ T
Control
group
27.11 ± 0.50 13.12 ± 0.59 2.07 ± 0.11
Group
25(OH)D3
25.31 ± 0.32 11.50 ± 0.55 2.20 ± 0.13
t 9.588 6.351 −2.414
P 0.000 0.000 0.0273.5. Effect of 25(OH)D3 in distribution of CD4+T and
CD8+T
The results showed that the accounts for CD4+ T cells of the
control group were signiﬁcantly higher than those of 25(OH)D3
(P < 0.05). The values of CD4+ T/CD8+ T in 25(OH)D3 were
signiﬁcantly higher than those in the control group (P < 0.05)
(Table 3).
4. Discussion
Former studies showed that 25(OH)D3 deﬁciency had a close
relation with tuberculosis susceptibility [19]. However, there are
few researches on genic polymorphism and tuberculosis
susceptibility of vitamin D receptor TaqI and FokI and there
are still some disagreements [20–22]. Therefore, a further study
of the action mechanism of vitamin D3 in tuberculosis therapy
is very important.
Immunity in tuberculosis includes innate immunity and ac-
quired immune. Many studies have reported that 25(OH)D3
inﬂuences the concrete mechanism of its innate immunity [23].
Nevertheless, studies about the effect of 25(OH)D3 in
tuberculosis acquired immune are not deep-going enough. In
the procedure of T cells activation by tuberculosis infection,
DCs play a very important role there. Studies have shown that
100 nmol/L is in the normal range of physiological concentra-
tion of 25(OH)D3. Deﬁciency of vitamin D3 refers to the lack of
25(OH)D3, so studies on the effects of 25(OH)D3 in DCs
remain extremely important [3]. In this study, we mainly
investigate the changes of DCs’ phenotypes and functions
after those DCs become mature by the stimulation of 5 mg/mL
of BCG with the presence of 100 nmol/L of 25(OH)D3.
Compared with the control group, we found that the positive
rate of CD86 of DCs’ surfaces in group 25(OH)D3 signiﬁcantly
decreased, while the rate of CD11C, CD80 and MHC-II in the
two groups showed no obvious differences. Besides, the average
ﬂuorescence intensity of MHC-II in the control group was
signiﬁcantly higher than in group 25(OH)D3. CD11C is an
important tagged molecule of the detection of DCs, while CD80,
CD86 and MHC-II are superﬁcial co-stimulatory molecules in
the procedure of differentiation of DCs. The data of the study
showed that 25(OH)D3 deceased the expressions of MHC-II and
CD86. There were researches showing that the decreases of
MHC-II and CD86 were common features of functional dam-
ages of DCs in all kinds of 25(OH)D3 models [24]. This study
data also manifested that 25(OH)D3 could not only inhibit
DCs from maturity, but also weaken its antigen-presenting
capacity.
What's more, BCG was used to stimulate the two groups in
the study. Compared with the control group, we found that the
percentages of CD4+ T and CD8+ T cells in group 25(OH)D3
signiﬁcantly decreased, while the ratio of CD4+ T/CD8+ T
increased obviously. These data indicated that lack of 25(OH)D3
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bodies, which consistently matched with the in vitro experiment
that 25(OH)D3 could weaken the antigen-presenting capacity of
DCs and inhibit the T cells from proliferation. The decrease of
the ratio of CD4+ T/CD8+ T in the control group was a main
manifestation of immune damage in tuberculosis patients.
In conclusion, it is found in this study that 100 nmol/L of
25(OH)D3 decreases the expressions of DCs’ superﬁcial co-
stimulatory molecules MHC-II and CD86 so as to weaken the
antigen-presenting capacity of DCs and inhibit the T cells from
proliferation. Further researches about the effects of 100 nmol/L
of 25(OH)D3 on in vivo DCs of patients infected by Mycobac-
terium tuberculosis are conductive to the achievement of a new
tuberculosis therapy project.
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